Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples